Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
Ontology highlight
ABSTRACT: Integrin alpha(5)beta(1) is expressed on several types of cancer cells, including colon cancer, and plays an important role in tumor growth and metastasis. The ability to target the integrin alpha(5)beta(1) using an appropriate drug delivery nano-vector can significantly help in inhibiting tumor growth, reducing tumor metastasis, and decreasing deleterious side effects associated with different cancer therapies. Liposomes are nano-sized phospholipid bilayer vesicles that have been extensively studied as drug delivery carriers. The goal of this study is to design stealth liposomes (liposomes covered with polyethylene glycol (PEG)) that will target colon cancer cells that express the integrin alpha(5)beta(1). The PEG provides a steric barrier allowing the liposomes to circulate in the blood
SUBMITTER: Garg A
PROVIDER: S-EPMC2660894 | biostudies-literature | 2009 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA